US Stock MarketDetailed Quotes

Jasper Therapeutics (JSPR)

Watchlist
  • 1.570
  • +0.050+3.29%
Close Jan 22 16:00 ET
43.93MMarket Cap-0.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jasper Therapeutics (JSPR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-3.64%19.17M
69.30%27.08M
44.65%21.8M
10.71%76.24M
42.65%25.29M
2.72%19.89M
-10.29%15.99M
8.07%15.07M
34.50%68.86M
28.94%17.73M
Selling and administrative expenses
-12.13%4.78M
25.19%5.88M
18.24%5.65M
19.57%20.42M
41.72%5.51M
20.38%5.43M
3.69%4.7M
15.26%4.77M
3.06%17.08M
-12.88%3.89M
-General and administrative expense
-12.13%4.78M
25.19%5.88M
18.24%5.65M
19.57%20.42M
41.72%5.51M
20.38%5.43M
3.69%4.7M
15.26%4.77M
3.06%17.08M
-12.88%3.89M
Research and development costs
-0.44%14.39M
87.64%21.2M
56.89%16.16M
7.79%55.82M
42.91%19.77M
-2.65%14.46M
-15.05%11.3M
5.03%10.3M
49.55%51.79M
49.05%13.84M
Operating profit
3.64%-19.17M
-69.30%-27.08M
-44.65%-21.8M
-10.71%-76.24M
-42.65%-25.29M
-2.72%-19.89M
10.29%-15.99M
-8.07%-15.07M
-34.50%-68.86M
-28.94%-17.73M
Net non-operating interest income expense
-73.36%342K
-69.86%437K
-54.98%624K
-2.71%5.06M
-23.99%938K
-10.40%1.28M
0.97%1.45M
26.46%1.39M
641.65%5.2M
254.60%1.23M
Non-operating interest income
-73.36%342K
-69.86%437K
-54.98%624K
-2.71%5.06M
-23.99%938K
-10.40%1.28M
0.97%1.45M
26.46%1.39M
641.65%5.2M
254.60%1.23M
Other net income (expense)
375.00%88K
-110.00%-84K
-50.00%-63K
89.04%-88K
128.89%26K
-108.31%-32K
-112.86%-40K
97.02%-42K
-106.27%-803K
-147.87%-90K
Gain on sale of security
--2.1M
----
----
----
----
----
----
----
-107.99%-575K
--0
Special income (charges)
----
----
----
--0
--0
-94.01%20K
--0
97.38%-20K
-99.69%18K
-67.06%28K
-Less：Restructuring and merger&acquisition
----
----
----
--0
--0
94.01%-20K
--0
-97.38%20K
99.69%-18K
67.06%-28K
Other non- operating income (expenses)
-6,184.38%-2.01M
-110.00%-84K
-50.00%-63K
64.23%-88K
122.03%26K
-162.75%-32K
63.30%-40K
40.00%-42K
-113.91%-246K
-151.06%-118K
Income before tax
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
Income tax
Net income
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
Net income continuous Operations
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
Minority interest income
Net income attributable to the parent company
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
Basic earnings per share
8.87%-1.13
-79.38%-1.74
-36.89%-1.41
-691.26%-4.89
-8.00%-1.62
22.50%-1.24
34.01%-0.97
36.42%-1.03
94.02%-0.618
58.33%-1.5
Diluted earnings per share
8.87%-1.13
-79.38%-1.74
-36.89%-1.41
-691.26%-4.89
-8.00%-1.62
22.50%-1.24
34.01%-0.97
36.42%-1.03
94.02%-0.618
58.33%-1.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -3.64%19.17M69.30%27.08M44.65%21.8M10.71%76.24M42.65%25.29M2.72%19.89M-10.29%15.99M8.07%15.07M34.50%68.86M28.94%17.73M
Selling and administrative expenses -12.13%4.78M25.19%5.88M18.24%5.65M19.57%20.42M41.72%5.51M20.38%5.43M3.69%4.7M15.26%4.77M3.06%17.08M-12.88%3.89M
-General and administrative expense -12.13%4.78M25.19%5.88M18.24%5.65M19.57%20.42M41.72%5.51M20.38%5.43M3.69%4.7M15.26%4.77M3.06%17.08M-12.88%3.89M
Research and development costs -0.44%14.39M87.64%21.2M56.89%16.16M7.79%55.82M42.91%19.77M-2.65%14.46M-15.05%11.3M5.03%10.3M49.55%51.79M49.05%13.84M
Operating profit 3.64%-19.17M-69.30%-27.08M-44.65%-21.8M-10.71%-76.24M-42.65%-25.29M-2.72%-19.89M10.29%-15.99M-8.07%-15.07M-34.50%-68.86M-28.94%-17.73M
Net non-operating interest income expense -73.36%342K-69.86%437K-54.98%624K-2.71%5.06M-23.99%938K-10.40%1.28M0.97%1.45M26.46%1.39M641.65%5.2M254.60%1.23M
Non-operating interest income -73.36%342K-69.86%437K-54.98%624K-2.71%5.06M-23.99%938K-10.40%1.28M0.97%1.45M26.46%1.39M641.65%5.2M254.60%1.23M
Other net income (expense) 375.00%88K-110.00%-84K-50.00%-63K89.04%-88K128.89%26K-108.31%-32K-112.86%-40K97.02%-42K-106.27%-803K-147.87%-90K
Gain on sale of security --2.1M-----------------------------107.99%-575K--0
Special income (charges) --------------0--0-94.01%20K--097.38%-20K-99.69%18K-67.06%28K
-Less：Restructuring and merger&acquisition --------------0--094.01%-20K--0-97.38%20K99.69%-18K67.06%-28K
Other non- operating income (expenses) -6,184.38%-2.01M-110.00%-84K-50.00%-63K64.23%-88K122.03%26K-162.75%-32K63.30%-40K40.00%-42K-113.91%-246K-151.06%-118K
Income before tax -0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M
Income tax
Net income -0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M
Net income continuous Operations -0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M
Minority interest income
Net income attributable to the parent company -0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M
Basic earnings per share 8.87%-1.13-79.38%-1.74-36.89%-1.41-691.26%-4.89-8.00%-1.6222.50%-1.2434.01%-0.9736.42%-1.0394.02%-0.61858.33%-1.5
Diluted earnings per share 8.87%-1.13-79.38%-1.74-36.89%-1.41-691.26%-4.89-8.00%-1.6222.50%-1.2434.01%-0.9736.42%-1.0394.02%-0.61858.33%-1.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -